CDKN2A and Miyoshi myopathy: Recent investigations into the genetic factors that underlie MM pathogenesis have identified frequent mutations in CDKN2A/ARF, NF2, BRCA1-associated protein 1 (BAP1), and TP53, albeit only very rare mutations in other well-known oncogenes [8].